These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 19926293)
1. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents. Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293 [TBL] [Abstract][Full Text] [Related]
2. Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections. Carvalheiro M; Esteves MA; Santos-Mateus D; Lopes RM; Rodrigues MA; Eleutério CV; Scoulica E; Santos-Gomes G; Cruz ME Eur J Pharm Biopharm; 2015 Jun; 93():346-52. PubMed ID: 25936854 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids. Papanastasiou I; Prousis KC; Georgikopoulou K; Pavlidis T; Scoulica E; Kolocouris N; Calogeropoulou T Bioorg Med Chem Lett; 2010 Sep; 20(18):5484-7. PubMed ID: 20719503 [TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of antileishmanial activity and toxicity of essential oils of Artemisia absinthium and Echinops kebericho. Tariku Y; Hymete A; Hailu A; Rohloff J Chem Biodivers; 2011 Apr; 8(4):614-23. PubMed ID: 21480507 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives. Calogeropoulou T; Angelou P; Detsi A; Fragiadaki I; Scoulica E J Med Chem; 2008 Feb; 51(4):897-908. PubMed ID: 18220332 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones. Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420 [TBL] [Abstract][Full Text] [Related]
7. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents. Singh FV; Vatsyayan R; Roy U; Goel A Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents. Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents. Pandey S; Suryawanshi SN; Gupta S; Srivastava VM Eur J Med Chem; 2005 Aug; 40(8):751-6. PubMed ID: 15907348 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives. Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani. Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140 [TBL] [Abstract][Full Text] [Related]
12. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum. Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661 [TBL] [Abstract][Full Text] [Related]
16. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi. de Oliveira-Silva F; de Morais-Teixeira E; Rabello A Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes. Azzouz S; Lawton P Acta Parasitol; 2017 Sep; 62(3):582-588. PubMed ID: 28682767 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a new antileishmanial hit in 8-nitroquinoline series. Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents. Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity. Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]